Close



Apr 8, 2024 08:00AM
Mar 26, 2024 07:07PM
Mar 26, 2024 08:00AM
Mar 19, 2024 12:20PM
Mar 19, 2024 12:20PM
Mar 13, 2024 08:00AM
Mar 13, 2024 08:00AM Takeda Announces Positive Topline Results from Phase 2 Study Evaluating Mezagitamab (TAK-079), a Potential Best-in-Class Anti-CD38 Monoclonal Antibody, for Primary Immune Thrombocytopenia
Feb 26, 2024 11:30PM
Feb 12, 2024 08:03AM
Feb 12, 2024 08:00AM
Feb 9, 2024 02:30AM
Feb 8, 2024 06:00PM
Feb 1, 2024 05:44AM
Feb 1, 2024 01:54AM Takeda Announces Chief Financial Officer Succession
Feb 1, 2024 01:02AM
Jan 31, 2024 04:09PM
Jan 31, 2024 04:05PM
Jan 29, 2024 11:10AM
Jan 29, 2024 11:10AM
Jan 29, 2024 05:55AM
Jan 29, 2024 02:00AM Takeda’s HYQVIA® Approved by European Commission as Maintenance Therapy in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Jan 18, 2024 07:00AM
Jan 16, 2024 08:04AM
Jan 16, 2024 08:00AM
Dec 21, 2023 04:00PM
Dec 21, 2023 04:00PM
Dec 15, 2023 08:16AM
Dec 15, 2023 08:16AM Takeda Receives Positive CHMP Opinion for HYQVIA® as Maintenance Therapy in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Nov 27, 2023 08:00AM
Nov 9, 2023 03:50PM
Nov 9, 2023 03:50PM
Nov 8, 2023 05:57PM
Nov 8, 2023 05:54PM
Nov 7, 2023 10:00AM
Nov 7, 2023 10:00AM Takeda Announces Late-Breaking Data from Phase 2b Study of TAK-279, an Investigational, Oral, Once-Daily TYK2 Inhibitor, in Patients with Active Psoriatic Arthritis at American College of Rheumatology
Oct 26, 2023 02:00AM
Oct 18, 2023 04:30PM
Oct 18, 2023 04:30PM
Oct 17, 2023 07:31PM
Oct 17, 2023 07:31PM
Oct 17, 2023 07:30PM
Oct 17, 2023 07:30PM Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
Oct 3, 2023 04:50PM
Oct 2, 2023 04:35PM
Oct 2, 2023 04:30PM
Sep 27, 2023 04:26PM
Sep 27, 2023 04:25PM
Sep 25, 2023 08:45AM
Sep 25, 2023 08:44AM Takeda Announces Approval of CUVITRU™ Subcutaneous Immunoglobulin in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia
Sep 20, 2023 08:02AM

921,822 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All